|
Volumn 29, Issue 1-2, 1997, Pages 777-780
|
Limited benefits of INF-α therapy in renal graft candidates with chronic viral hepatitis B or C
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
RECOMBINANT ALPHA INTERFERON A;
RECOMBINANT ALPHA2B INTERFERON;
ADULT;
CHRONIC HEPATITIS;
CLINICAL ARTICLE;
CONFERENCE PAPER;
FEMALE;
GRAFT REJECTION;
HEPATITIS B;
HEPATITIS C;
HISTOPATHOLOGY;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
KIDNEY FAILURE;
KIDNEY TRANSPLANTATION;
MALE;
PRIORITY JOURNAL;
SUBCUTANEOUS DRUG ADMINISTRATION;
TREATMENT OUTCOME;
DNA, VIRAL;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
HEPACIVIRUS;
HEPATITIS B;
HEPATITIS B VIRUS;
HEPATITIS C;
HUMANS;
INTERFERON ALFA-2B;
KIDNEY FAILURE, CHRONIC;
KIDNEY TRANSPLANTATION;
LIVER;
PATIENT SELECTION;
RECURRENCE;
RENAL DIALYSIS;
VIREMIA;
|
EID: 0030909705
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(96)00098-X Document Type: Conference Paper |
Times cited : (22)
|
References (29)
|